Navigation Links
Graphic Design Company, Project6 Design, Launches New Brand And Responsive Website For Innovative Biotech Company PaxVax
Date:12/19/2012

Berkeley, CA (PRWEB) December 19, 2012

San Francisco Bay Area branding and graphic design company Project6 Design, is proud to announce the unveiling of a new responsive design website and brand identity for biotech company PaxVax, which is developing affordable oral vaccinations for infectious diseases around the world. The new design highlights the diseases that PaxVax fights with its innovative technology, and a rollover map that features hotspots around the world where the company’s work will have the greatest impact. The design also includes a reworking of the PaxVax logo and updating the company’s brand identity and color palette.

Site visitors can now find information about the vaccinations that PaxVax is creating, including updates about their clinical trials, and useful information about the most common virulent infectious diseases and the risk they pose worldwide. It also gives an understanding about the company’s desire to provide both financial and social returns with their double bottom line business.

The new site was build using the Drupal content management system (CMS), a core strength of Project6 Design’s web development team. Drupal is a free, community-based CMS web development platform used by organizations small and large, including Sony Music, AOL Corporate, Popular Science, Fast Company and the White House to name a few. The site was also created using responsive design methods, enabling its viewable content to easily adjust to a multitude of various screen sizes found in web capable devices. This makes the new PaxVax site truly iPad/tablet and iPhone/mobile friendly for users.

“Working with the Project6 Design team really helped us reach a new level for our brand,” said Nima Farzan, Executive Vice President & Chief Operating Officer of PaxVax. “They understood our need for differentiation in the highly competitive biotech marketplace. Project6 was also able to highlight our innovative vaccine technology while not losing the social perspective of what we do. We are getting great feedback on the brand and the website and are really pleased by the results.”

“PaxVax is hoping to change the world, to be a game-changer with their vaccination technology,” says Project6 Design Founder and President, Esten Sesto. “We wanted the new brand to make them more relevant in the pharmaceutical marketplace, yet in a way that differentiated what they do. We’re really excited that the new brand is being well received and look forward to watching PaxVax grow.”

About PaxVax
PaxVax is a privately held company established in 2007 to develop and commercialize innovative vaccines against infectious diseases. PaxVax has a clinical-stage product portfolio, including a cholera vaccine entering Phase 3 and a pandemic H5N1 influenza vaccine entering Phase 2. The company also has vaccines in development for HIV and anthrax under R&D contracts with NIH. The company’s proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target any viral or bacterial protein antigen. The company's vaccine candidates are designed to be easier to manufacture, store, distribute, administer and deliver across the globe than conventional injectable vaccines while enhancing the desired immune response to the vaccine antigens. The company’s offices are headquartered in Menlo Park, Calif., and the R&D laboratories and licensed GMP production facility are based in San Diego, Calif.
http://www.paxvax.com/

About Project6 Design, Inc.
Project6 Design, established in 2001, is an award-winning San Francisco Bay Area (Berkeley, CA) based graphic design company that specializes in strategic brand, print, web design, and development services. Their unique process helps clients differentiate, validate their brand, and solve complex usability problems. Experts in the areas of High Tech, Retail, Education, and Nonprofit, clients include the Serena Software, eBay, CA Technologies, Old Navy, Gap, University of California - San Francisco, Stanford University, United Way, and the Siebel Foundation. For more information, call (510) 540-8005, email info[at]project6[dot]com, or visit http://www.project6.com.

Contact:
Project6 Design, Inc.
Esten Sesto
President
(510) 540-8005 ext. 100
esten[at]project6[dot]com

###

Read the full story at http://www.prweb.com/releases/project6-design/paxvax-responsive-website/prweb10249614.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Computers & Graphics incorporates Collage Authoring Environment
2. CANVUS Design Studio Specializes in Graphic Design and Commercials
3. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
6. Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
7. Design eye for the science guy: Drop-in clinic helps scientists communicate data
8. Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
9. Increased fertility rate for IVF patients achieved by new equipment design
10. Molecular graphene heralds new era of designer electrons
11. Designer lights from the physics lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):